Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene.

Chiara Balducci, Cinzia Lilli, Giordano Stabellini, Lorella Marinucci, Giammario Giustozzi, Alessio Becchetti, Lucio Cagini, Paola Locci

Journal: BMC cancer 2005;5():22

PMID: 15740610

Abstract

BACKGROUND

Desmoid tumour is a benign, non metastasising neoplasm characterised by an elevated deposition of organic macromolecules in the extracellular matrix (ECM). The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the degradation of ECM macromolecules. The MMPs and their natural inhibitors (TIMPs) have been implicated in tumour growth, invasion and metastasis. In this study we provide evidence that the in vitro cultured cell line from desmoid tumour accumulates more collagen fibres in the ECM than healthy fibroblasts.

METHODS

We investigated collagen accumulation by 3H-thymidine incorporation, MMP expression by substrate gel zymography and TIMP expression by Western blot analysis.

RESULTS

Desmoid fibroblasts showed a reduction in MMP activity and an increase of type I and III collagen and TIMPs compared to normal fibroblasts.

CONCLUSION

The increase in collagen in desmoid fibroblasts was due to inhibited collagen degradation (reduction of MMP activity) rather than to increased collagen synthesis. Adding toremifene, an anti-estrogen triphenylethylene derivate, to desmoid fibroblasts reduced collagen accumulation by decreasing mRNA expression and increasing collagen degradation.

Address: Department of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy. [email protected] <[email protected]>
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.